Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-018630

Chief Legal Officer and Sec. acquired 43,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hadfield Robert Chief Legal Officer and Sec. 2021-03-04 Grant or award +43,500 176,819 D
Derivatives
Hadfield Robert Chief Legal Officer and Sec. 2021-03-04 Grant or award · Employee Stock Option (right to buy) +326,250 326,250 D
Loading xslF345X03/doc4.xml…